Our Mission

EFEVRE TECH combines an agile amalgamation of scientific experts towards a common goal.

Who We Are

Embracing a multifaceted Research and Development approach EFEVRE TECH focuses in the design, manufacture and retail of prototypes and innovative devices in the fields of Health science, Biology, environment management and alternative energy around the globe. Always having in mind customer needs and necessities!

Who We Are

Our Mission

EFEVRE TECH LTD's mission is to provide innovative software solutions and advance R&D in Health Science, Biology, Environment, and Alternative Energy, creating cutting-edge prototypes and devices that cater to global customer needs while inspiring collaboration and progress.

Our Mission

Our Vision

EFEVRE TECH LTD envisions itself as a global leader in research and innovation, fostering strategic partnerships to develop ground-breaking products. Our commitment to a multifaced R&D approach, customer-centric solutions, and worldwide impact will drive progress and inspire a sustainable future.

Our Vision

Our Journey

1

2

3

4

5

6

7

8

9

10

11

12

13

14 June 2018

EFEVRE TECH LTD is established as a company

November 2018

First Grant Approval as an Innovative Enterprise in Cyprus from the Ministry of Commerce

May 2019

European Grant Award for AMGEL Basic Device

May 2020

AMGEL Basic Device Prototype was completed and pilot tested at the University of Cyprus

December 2020

First Order of the AMGEL Basic Device at Agricultural Research Institute of Cyprus in an open tender

2022

Grand Fundings from the Cyprus Research and Innovation Center for new Automation Products

2023

Grand Fundings from the Cyprus Research and Innovation Center for five vouchers as collaborators for other companies

December 2023

AMGEL 247 Pro Prototype was completed and launch to the market

February 2024

Secured and Received an Investment for the development costs of the new AMGEL 4TT Device

December 2024

Launch of the new AMGEL 4TT Device in the field of Molecular Diagnostics

2024

ISO Certifications Secured for ISO 9001:2015 and ISO 14001:2015

2024

Collaboration with 50 leading scientific institutions in the EU through the establishment of the LIFESPIRIT Community

2024

European Patent Approved in 26 countries for AMGEL Technology, including Germany, England and France

January 2025

First Order of AMGEL 4TT Device delivery at the University of Cambridge in the Automation of New Molecular Diagnostic Methods